These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2014713)

  • 1. Relationship between gliadin peptide structure and their effect on the fetal chick duodenum.
    Kocna P; Mothes T; Krchnák V; Fric P
    Z Lebensm Unters Forsch; 1991 Feb; 192(2):116-9. PubMed ID: 2014713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
    De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
    Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between gliadin structure and coeliac toxicity.
    Wieser H
    Acta Paediatr Suppl; 1996 May; 412():3-9. PubMed ID: 8783747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies of the in vitro activity of synthetic gliadin peptides in coeliac disease.
    Cornell H; Mothes T
    Biochim Biophys Acta; 1995 Apr; 1270(2-3):168-72. PubMed ID: 7727540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The precipitating factor in coeliac disease.
    Wieser H
    Baillieres Clin Gastroenterol; 1995 Jun; 9(2):191-207. PubMed ID: 7549024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of wheat gliadin peptides in in vitro assays for coeliac disease.
    Cornell HJ; Mothes T
    Biochim Biophys Acta; 1993 Apr; 1181(2):169-73. PubMed ID: 8481406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease.
    Cornell H; Wieser H; Belitz HD
    Clin Chim Acta; 1992 Dec; 213(1-3):37-50. PubMed ID: 1477986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
    de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
    Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational studies of peptides corresponding to the coeliac-activating regions of wheat alpha-gliadin.
    Tatham AS; Marsh MN; Wieser H; Shewry PR
    Biochem J; 1990 Sep; 270(2):313-8. PubMed ID: 2400392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and enzymatic fragmentation of the coeliac-active gliadin peptide CT-1.
    Wieser H; Belitz HD
    Z Lebensm Unters Forsch; 1992 Jul; 195(1):22-6. PubMed ID: 1502855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous-flow synthesis of alpha-gliadin peptides in an ultrasonic field and assay of their inhibition of intestinal sucrase activity.
    Vágner J; Kocna P; Krchnák V
    Pept Res; 1991; 4(5):284-8. PubMed ID: 1839365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro toxicity of purified gluten peptides tested by organ culture.
    Fluge O; Sletten K; Fluge G; Aksnes L; Elsayed S
    J Pediatr Gastroenterol Nutr; 1994 Feb; 18(2):186-92. PubMed ID: 8014766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of gliadin on fetal chick intestine in tissue culture.
    Mothes T; Mühle W; Müller F; Hekkens WT
    Biol Neonate; 1985; 48(1):59-64. PubMed ID: 3899195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease.
    McLachlan A; Cullis PG; Cornell HJ
    J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in caco-2 cells by wheat gliadin peptides.
    Giovannini C; Sanchez M; Straface E; Scazzocchio B; Silano M; De Vincenzi M
    Toxicology; 2000 Apr; 145(1):63-71. PubMed ID: 10771132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta structure motif recognition by anti-gliadin antibodies in coeliac disease.
    Alfonso P; Soto C; Albar JP; Camafeita E; Escobar H; Suárez L; Rico M; Bruix M; Méndez E
    FEBS Lett; 1998 May; 427(1):36-40. PubMed ID: 9613595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyproline, beta-turn helices. Novel secondary structures proposed for the tandem repeats within rhodopsin, synaptophysin, synexin, gliadin, RNA polymerase II, hordein, and gluten.
    Matsushima N; Creutz CE; Kretsinger RH
    Proteins; 1990; 7(2):125-55. PubMed ID: 2139224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.
    Martucci S; Fraser JS; Biagi F; Corazza GR; Ciclitira PJ; Ellis HJ
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1293-8. PubMed ID: 14624152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of reactive synthetic gliadin peptides specific for coeliac disease.
    Devery JM; Bender V; Penttila I; Skerritt JH
    Int Arch Allergy Appl Immunol; 1991; 95(4):356-62. PubMed ID: 1720424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships in coeliac-toxic gliadin peptides.
    Cornell HJ; Wills-Johnson G
    Amino Acids; 2001; 21(3):243-53. PubMed ID: 11764405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.